Medical device contract manufacturing market seen topping $226 billion by 2030

By AI, Created 2:45 PM UTC, May 22, 2026, /AGP/ – The Business Research Company projects the global medical device contract manufacturing market will reach $226.84 billion by 2030, driven by outsourcing, regulatory pressure and demand for advanced devices. North America is expected to lead the market, while drug delivery devices remain the biggest segment.

Why it matters: - The market is projected to nearly double by 2030, signaling more outsourcing across the medical device supply chain. - Contract manufacturing is becoming more central as device makers look for lower costs, faster scale-up and stronger compliance support. - The category is expected to represent nearly 19% of the broader medical equipment market, which TBRC forecasts at $1,176 billion by 2030.

What happened: - The Business Research Company released a report projecting the medical device contract manufacturing market will reach $226.84 billion by 2030. - The forecast implies a 15% compound annual growth rate from 2025 to 2030. - The report was published May 22, 2026. - Request a free sample of the report - Access the full report

The details: - North America is forecast to be the largest region in 2030 at $94 billion, up from $47 billion in 2025, for 15% annual growth. - The USA is projected to be the largest country in the market in 2030 at $83 billion, rising from $42 billion in 2025 at a 14% CAGR. - The drug delivery devices segment is expected to be the largest by device type, accounting for 29% of the market, or $67 billion, in 2030. - The market is segmented by device into IVD devices, diagnostic imaging devices, cardiovascular devices, drug delivery devices, endoscopy devices, ophthalmology devices, orthopedic devices, dental devices and other devices. - The market is segmented by service into device development and manufacturing services, quality management services and assembly services. - The market is segmented by application into design and prototyping, component manufacturing, device assembly and integration, packaging and sterilization, quality assurance and testing, regulatory and compliance support, and lifecycle management and scale-up manufacturing. - TBRC says the drug delivery segment is supported by chronic disease prevalence, demand for autoinjectors and wearable injectors, biologics pipelines and device innovation.

Between the lines: - The forecast points to a broader shift toward specialized partners for complex manufacturing, not just low-cost production. - Regulatory complexity is becoming a competitive moat for contract manufacturers with established quality and compliance systems. - Advanced manufacturing capabilities such as automation, robotics, additive manufacturing and digital production are increasingly part of the value proposition. - TBRC says cost optimization, compliance demands and advanced manufacturing needs are the main growth drivers. - The firm estimates cost optimization contributes about 2.5% annual growth, regulatory complexity about 2.0% and advanced manufacturing capabilities about 1.7%. - The report also sees growth opportunities across IVD, diagnostic imaging, cardiovascular, drug delivery, endoscopy, ophthalmology, orthopedic, dental and other device categories. - Those segments are projected to add more than $113 billion in market value by 2030.

What’s next: - The market is expected to keep expanding through 2030 as OEMs outsource more development, assembly and compliance work. - The report points to continued investment in precision engineering, digital manufacturing and device design. - Faster adoption of minimally invasive, wearable and implantable devices should keep demand elevated across major regions.

The bottom line: - Medical device contract manufacturing is shifting from a back-office function to a core strategy for scaling complex devices, managing regulation and controlling costs.